ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Cameron D. Wright
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wright, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wright, C. D.
Related Collections
Right arrow Mediastinum

Ann Thorac Surg 2006;82:1234-1239
© 2006 The Society of Thoracic Surgeons

Original Articles: General Thoracic

Pleuropneumonectomy for the Treatment of Masaoka Stage IVA Thymoma

Cameron D. Wright, MD*

Division of Thoracic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

Accepted for publication May 8, 2006.

* Address correspondence to Dr Wright, Division of Thoracic Surgery, Massachusetts General Hospital, Harvard Medical School, Blake 1570, 55 Fruit St, Boston, MA 02114 (Email: cameron{at}mgh.harvard.edu).

BACKGROUND: The treatment of locally advanced Masaoka stage IVA thymoma is not standardized and is problematic.

METHODS: A single-institution retrospective study was made of 5 patients with World Health Organization B3 thymomas who underwent pleuropneumonectomy for locally advanced thymoma. Two patients had recurrent thymoma and 3 presented de novo with stage IVA disease. Patients had a variety of induction and adjuvant treatments.

RESULTS: There was no operative mortality, and only 1 patient had a major complication. Several patients had relatively prolonged disease-free survival. The median survival was 86 months, and the Kaplan-Meier survival was 75% (95% confidence interval: 53% to 97%) at 5 years and 50% (95% confidence interval: 25% to 75%) at 10 years.

CONCLUSIONS: Pleuropneumonectomy can be performed safely in patients with advanced thymomas and may improve survival. Highly selected patients might be cured with this approach if a complete resection is performed. While the optimal multimodality strategy for these patients is unknown, induction chemotherapy followed by resection then chemoradiotherapy seems promising.




This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
M. Lucchi, F. Basolo, and A. Mussi
Surgical treatment of pleural recurrence from thymoma
Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 707 - 711.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. Huang, G. J. Riely, K. E. Rosenzweig, and V. W. Rusch
Multimodality Therapy for Locally Advanced Thymomas: State of the Art or Investigational Therapy?
Ann. Thorac. Surg., February 1, 2008; 85(2): 365 - 367.
[Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. Huang, N. P. Rizk, W. D. Travis, V. E. Seshan, M. S. Bains, J. Dycoco, R. J. Downey, R. M. Flores, B. J. Park, and V. W. Rusch
Feasibility of multimodality therapy including extended resections in stage IVA thymoma.
J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1477 - 1484.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.